Literature DB >> 26414495

Curcuminoids Modulate the PKCδ/NADPH Oxidase/Reactive Oxygen Species Signaling Pathway and Suppress Matrix Invasion during Monocyte-Macrophage Differentiation.

Shao-Lan Huang, Pei-Yi Chen1, Ming-Jiuan Wu2, Mi-Hsueh Tai, Chi-Tang Ho3, Jui-Hung Yen.   

Abstract

Monocyte recruitment and invasion play critical roles in the initiation and progression of atherosclerosis. The reduction in monocyte adhesion and infiltration is thought to exert antiatherosclerotic effects. Curcumin, demethoxycurcumin (DMC), and bisdemethoxycurcumin (BDMC) are the major active components of curcuminoids and exhibit several biological activities, including anti-inflammatory, anticarcinogenic, and hypocholesterolemic activities. The aim of this study was to investigate the antiatherogenic effects and mechanisms of curcuminoids during monocyte to macrophage differentiation. The results showed that curcumin, DMC, and BDMC (20 μM) suppressed matrix invasion from 100.0 ± 5.0% to 24.8 ± 1.4%, 26.6 ± 2.9%, and 33.7 ± 1.7%, respectively, during PMA-induced THP-1 differentiation. We found that curcuminoids significantly reduced PMA-induced CD11b and MMP-9 expression by THP-1 cells. Production of reactive oxygen species (ROS) induced by PMA (126.7 ± 2.1%) was markedly attenuated by curcumin, DMC, and BDMC to 99.5 ± 7.8%, 87.8 ± 8.2%, and 89.8 ± 7.6%, respectively, resulting in the down-regulation of CD11b and MMP-9 expression. We demonstrated that curcuminoids inhibited NADPH oxidase through the down-regulation of NOX2 expression and the reduction of p47phox membrane translocation. Moreover, we found involvement of PKCδ in the PMA-induced NOX2, CD11b, and MMP-9 mRNA expression. Curcumin, DMC, and BDMC decreased the active form of PKCδ protein stimulated by PMA in THP-1 cells. Overall, our results reveal that curcuminoids suppress matrix invasion through the inhibition of the PKCδ/NADPH oxidase/ROS signaling pathway during monocyte-macrophage differentiation.

Entities:  

Keywords:  CD11b; NADPH oxidase; PKCδ; atherosclerosis; curcuminoids

Mesh:

Substances:

Year:  2015        PMID: 26414495     DOI: 10.1021/acs.jafc.5b04083

Source DB:  PubMed          Journal:  J Agric Food Chem        ISSN: 0021-8561            Impact factor:   5.279


  7 in total

Review 1.  Chinese Herbal Medicines and Active Metabolites: Potential Antioxidant Treatments for Atherosclerosis.

Authors:  Luxia Song; Jie Zhang; Runmin Lai; Qiuyi Li; Jianqing Ju; Hao Xu
Journal:  Front Pharmacol       Date:  2021-05-13       Impact factor: 5.810

2.  The Novel HDAC8 Inhibitor WK2-16 Attenuates Lipopolysaccharide-Activated Matrix Metalloproteinase-9 Expression in Human Monocytic Cells and Improves Hypercytokinemia In Vivo.

Authors:  Jing-Shiun Jan; Yung-Chen Chou; Yu-Wen Cheng; Chih-Kuang Chen; Wei-Jan Huang; George Hsiao
Journal:  Int J Mol Sci       Date:  2017-06-29       Impact factor: 5.923

3.  Curcumin Alleviates oxLDL Induced MMP-9 and EMMPRIN Expression through the Inhibition of NF-κB and MAPK Pathways in Macrophages.

Authors:  Jiatian Cao; Bozhi Ye; Lu Lin; Lei Tian; Hongbo Yang; Changqian Wang; Weijian Huang; Zhouqing Huang
Journal:  Front Pharmacol       Date:  2017-02-14       Impact factor: 5.810

Review 4.  Antioxidant supplements and endurance exercise: Current evidence and mechanistic insights.

Authors:  Shaun A Mason; Adam J Trewin; Lewan Parker; Glenn D Wadley
Journal:  Redox Biol       Date:  2020-02-20       Impact factor: 11.799

5.  Protection Against Radiation-Induced Micronuclei in Rat Bone Marrow Erythrocytes by Curcumin and Selenium L-Methionine.

Authors:  Hamed Bagheri; Saeed Rezapour; Masoud Najafi; Elahe Motevaseli; Babak Shekarchi; Mohsen Cheki; Hossein Mozdarani
Journal:  Iran J Med Sci       Date:  2018-11

Review 6.  Antiviral and immunomodulatory activity of curcumin: A case for prophylactic therapy for COVID-19.

Authors:  Rajesh K Thimmulappa; Kiran Kumar Mudnakudu-Nagaraju; Chandan Shivamallu; K J Thirumalai Subramaniam; Arun Radhakrishnan; Suresh Bhojraj; Gowthamarajan Kuppusamy
Journal:  Heliyon       Date:  2021-02-22

Review 7.  Role and Mechanism of PKC-δ for Cardiovascular Disease: Current Status and Perspective.

Authors:  Li-Na Miao; Deng Pan; Junhe Shi; Jian-Peng Du; Peng-Fei Chen; Jie Gao; Yanqiao Yu; Da-Zhuo Shi; Ming Guo
Journal:  Front Cardiovasc Med       Date:  2022-02-15
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.